Walleye Capital

Walleye Capital’s Profound Medical PROF Stock Holding History

Walleye Capital’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,535	Closed	-$415K	–	1078
2020 Q3	$415K	Buy	+23,535	New	+$374K	0.05%	427

Other funds holding PROF

Fidelity International

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Walleye Capital's PROF Position: Q4 2020 in Review

Walleye Capital sold out of Profound Medical (PROF) in Q4 2020, closing a stake of 23,535 shares — an estimated $415K sold.

Walleye Capital first reported a position in PROF in Q3 2020 and held it in 1 quarter. The position peaked at $415K in Q3 2020. 56 funds tracked by Wall St. Rank hold PROF as of Q4 2020.

Walleye Capital reported no remaining Profound Medical position as of Q4 2020 after selling out during the quarter.
Walleye Capital sold 23,535 Profound Medical shares in Q4 2020, an estimated $415K.
Walleye Capital first reported a position in Profound Medical in Q3 2020 and held it in 1 quarter.
Walleye Capital's Profound Medical position peaked at $415K in Q3 2020.
56 funds tracked by Wall St. Rank held Profound Medical as of Q4 2020.

Based on Walleye Capital's 13F filing for Q4 2020, filed 16 Feb 2021.